article thumbnail

Inflation Reduction Act Imposes Prescription Drug Pricing Reforms

Healthcare Law Insights blog

The Act includes provisions targeting Medicare prescription drug costs, which could have wide-ranging effects for any party involved in the pharmaceutical industry, including drug developers, researchers, manufacturers, distributors, insurance companies, pharmacy associations and consumers. Indeed, one company, Alnylam Pharmaceuticals Inc.,